Literature DB >> 33779921

Extracellular Vesicles Regulate Cancer Metastasis.

Sanjay Shahi1, Cassandra Cianciarulo1, Christina Nedeva2, Suresh Mathivanan3.   

Abstract

Metastatic cancer is a complex disease associated with poor prognosis and accounts for the majority of cancer related deaths. To date, many of the molecular mechanisms driving metastatic disease remain elusive and require further investigation for the development of effective treatment strategies. Recent studies have shown that extracellular vesicles (EVs) can be exploited by tumors to assist in cancer cell growth, proliferation, migration, invasion and metastasis. Cancer cells have proven efficient in educating fibroblasts, within their microenvironment, to secrete EVs as communicative vessels for mediating phenotypic changes in recipient cells. Using this vesicular delivery system, cancer cells can establish a new metastatic niche within distant sites, away from the primary tumor, thus favoring cancer progression. These findings demonstrate the availability of a new route for therapeutic intervention in the inhibition of cancer dissemination. Although, several approaches to target cancer cell secretion of EVs are detailed in the literature, there is still no defined way to currently apply them in clinical settings. Hence, further studies are required to unravel the molecular mechanisms of metastasis - governed by the establishment and release of cancer associated EVs.

Entities:  

Keywords:  Angiogenesis; Cancer; Exosomes; Extracellular vesicles; Metastasis; Pre-metastatic niche

Mesh:

Year:  2021        PMID: 33779921     DOI: 10.1007/978-3-030-67171-6_11

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  82 in total

1.  Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer.

Authors:  Subir Biswas; Gunjan Mandal; Sougata Roy Chowdhury; Suman Purohit; Kyle K Payne; Carmen Anadon; Arnab Gupta; Patricia Swanson; Xiaoqing Yu; José R Conejo-Garcia; Arindam Bhattacharyya
Journal:  J Immunol       Date:  2019-11-08       Impact factor: 5.422

Review 2.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers.

Authors:  Stephanie Boukouris; Suresh Mathivanan
Journal:  Proteomics Clin Appl       Date:  2015-03-19       Impact factor: 3.494

Review 3.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

4.  The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro.

Authors:  Qian Cheng; Xin Li; Yue Wang; Min Dong; Feng-Huang Zhan; Jing Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

Review 5.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.

Authors:  Annette Becker; Basant Kumar Thakur; Joshua Mitchell Weiss; Han Sang Kim; Hector Peinado; David Lyden
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 31.743

6.  Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.

Authors:  Angélique Bobrie; Sophie Krumeich; Fabien Reyal; Chiara Recchi; Luis F Moita; Miguel C Seabra; Matias Ostrowski; Clotilde Théry
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

7.  Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.

Authors:  Gang Chen; Alexander C Huang; Wei Zhang; Gao Zhang; Min Wu; Wei Xu; Zili Yu; Jiegang Yang; Beike Wang; Honghong Sun; Houfu Xia; Qiwen Man; Wenqun Zhong; Leonardo F Antelo; Bin Wu; Xuepeng Xiong; Xiaoming Liu; Lei Guan; Ting Li; Shujing Liu; Ruifeng Yang; Youtao Lu; Liyun Dong; Suzanne McGettigan; Rajasekharan Somasundaram; Ravi Radhakrishnan; Gordon Mills; Yiling Lu; Junhyong Kim; Youhai H Chen; Haidong Dong; Yifang Zhao; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Meenhard Herlyn; E John Wherry; Xiaowei Xu; Wei Guo
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

8.  Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function.

Authors:  Els Beghein; Delphine Devriese; Evy Van Hoey; Jan Gettemans
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

Review 9.  Inhibiting extracellular vesicles formation and release: a review of EV inhibitors.

Authors:  Mariadelva Catalano; Lorraine O'Driscoll
Journal:  J Extracell Vesicles       Date:  2019-12-19

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.